<unk> , sold under the brand name Lenvima among others, is an anti-cancer medication for the treatment of certain kinds of thyroid cancer and for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.
Lenvatinib
Tucatinib
Neratinib
Fostamatinib
Lapatinib
Ponatinib
Selpercatinib
Infigratinib